EMEA-001045-PIP02-18

Key facts

Invented name
Kevzara
Active substance
sarilumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0335/2018
PIP number
EMEA-001045-PIP02-18
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of vasculitides
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Sanofi-aventis recherche et développement

Tel. +33 169745695
E-mail: contact-us@sanofi.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating